Jnana: Funding, Investors & Team (Sep 2026)
Jnana Therapeutics operates as a platform as a service company. The Company specializes in discovering and developing medicines that will make a difference for patients using the first drug discovery platform.
Jnana has raised $157M across 2 funding rounds on record, the most recent a Series C of $107M announced in Nov 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Jnana Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Jnana Funding Rounds
Jnana raised $50.0M in a Series B announced in Aug 2021.
1.3 years later, a Series C of $107M was announced in Nov 2022.
Jnana Founders and Leadership Team
Contact details for the Jnana team: 2 of 2 have an email address on file.
Start 14-day free trial →Jnana Funding Compared to Other Biotechnology Startups
Jnana's latest round of $107M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Jnana in Biotechnology and Boston
Companies Similar to Jnana
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Jnana Funding FAQs
What does Jnana do?
Jnana Therapeutics operates as a platform as a service company. The Company specializes in discovering and developing medicines that will make a difference for patients using the first drug discovery platform.
How much funding has Jnana raised?
Jnana has raised $157M across 2 rounds on record. The most recent is a Series C of $107M announced in Nov 2022.
When did Jnana last raise funding?
Jnana's most recent funding round on record is a Series C of $107M, announced in Nov 2022.
Who founded Jnana?
FundedIQ lists Joel Barrish (Founder) at Jnana.
Who is the CEO of Jnana?
Joanne Kotz is listed as CEO at Jnana.
Where is Jnana headquartered?
Jnana is based in Boston, Massachusetts, United States.
How many employees does Jnana have?
Jnana is in the 11-50 employee band.
How does Jnana's funding compare to other Biotechnology startups?
Jnana's latest round of $107M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Jnana Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Jnana is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.